IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 41 filers reported holding IMMUNE DESIGN CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 3.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,441,000 | -50.6% | 443,790 | -31.9% | 0.00% | -100.0% |
| Q3 2016 | $4,940,000 | +10.1% | 651,726 | +18.6% | 0.00% | 0.0% |
| Q2 2016 | $4,486,000 | -38.1% | 549,736 | -1.4% | 0.00% | -50.0% |
| Q1 2016 | $7,247,000 | -33.1% | 557,427 | +3.3% | 0.00% | 0.0% |
| Q4 2015 | $10,837,000 | +199.6% | 539,686 | +82.0% | 0.00% | +100.0% |
| Q3 2015 | $3,617,000 | -41.0% | 296,469 | -0.1% | 0.00% | 0.0% |
| Q2 2015 | $6,130,000 | +68.7% | 296,851 | +72.4% | 0.00% | 0.0% |
| Q1 2015 | $3,634,000 | -29.7% | 172,152 | +2.6% | 0.00% | 0.0% |
| Q4 2014 | $5,167,000 | +95.1% | 167,869 | +12.0% | 0.00% | 0.0% |
| Q3 2014 | $2,648,000 | – | 149,938 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,236,394 | $4,080,000 | 4.69% |
| Versant Venture Management, LLC | 2,208,210 | $7,287,093,000 | 2.33% |
| EcoR1 Capital, LLC | 4,437,600 | $14,422,000 | 1.45% |
| BVF INC/IL | 4,106,200 | $13,550,000 | 1.37% |
| Abingworth LLP | 352,300 | $1,145,000 | 0.71% |
| DAFNA Capital Management LLC | 328,500 | $1,084,000 | 0.53% |
| Bain Capital Public Equity Management, LLC | 1,680,987 | $5,547,000 | 0.40% |
| Telemetry Investments, L.L.C. | 248,800 | $821,000 | 0.31% |
| Stonepine Capital Management, LLC | 161,226 | $532,000 | 0.28% |
| Focused Wealth Management, Inc | 12,395 | $41,000 | 0.01% |